PODCAST: Treatment outcomes in schizophrenia – what matters to patients?

Our correspondent's highlights from the ECNP symposium (2019) are meant as a fair representation of the scientific content presented. The views and opinions expressed on this page do not necessarily reflect those of Lundbeck

 

AU-NOTPR-0243. November 2020

References
  1. Hasan et al. World J Biol Psychiatry 2013;14(1):2–44
  2. Lehman et al. APA Practice Guidelines, 2010
  3. NICE Guidance 2014 (Available from: https://www.nice.org.uk/guidance/cg178)
  4. Pietrini et al. Neuropsychiatr Dis Treat 2019;15:1045-1060
  5. Foot et al. The King’s Fund, 2014
  6. Bridges et al. Patient Prefer Adherence 2018;12:63–70
  7. Canadian Psychiatric Association. Can J Psychiatry 2005;50(13 Suppl 1):7S–57S
  8. Weiss et al. Poster at APA 2019
  9. Brissos et al. Psychiatry Res 2008;160(1):55–62; 
  10. Bobes et al. Dialogues Clin Neurosci 2007;9(2):215–226
  11. Carbon & Correll. Dialogues Clin Neurosci 2014;16(4):505–524
  12. Sackett et al. BMJ 1996;312(7023):71–72
  13. Citrome. Int J Clin Pract 2019;73(4):e13351
  14. Lieberman et al. N Engl J Med 2005;353(12):1209–1223
  15. Weiden & Buckley. J Clin Psychiatry 2007;68(Suppl 6):14–23
  16. Pinson & Gray. Psychiatr Serv 2003;54(2):145–146, 154
You are leaving Progress in Mind

Hello
Please, confirm your email address
We are sending you a confirmation link to your email address.
In order to get the access, please, check your email and confirm your registration.
The information on this site is exclusively intended for health care professionals.
All the information in this website is intended exclusively for Australian health care professionals and contains information pertaining to locally marketed products. Content regarding medication is informative. It is the responsibility of healthcare professionals to decide, on an individual basis, the most appropriate treatment to suit the needs of the patient.
Congress
Register for access to Progress in Mind in your country